Search results (65)
« Back to PublicationsP181 Bactericidal/ permeability-increasing protein is present in plasma of stable and exacerbating COPD patients
Conference paper
Wong YY. et al, (2024), ‘Catching Fire’ – Measuring and targeting inflammation in COPD, A216.1 - A216
T6 Exhaled nitric oxide (FeNO) predicts clinical and anti-inflammatory response to prednisolone for breakthrough attacks in anti-IL5/IL5R treated asthma
Conference paper
Howell I. et al, (2024), BTS/BALR/A+LUK Early Career Investigator Award Symposium, A5.2 - A6
S109 Treating eosinophilic exacerbations of asthma and COPD with benralizumab: a double blind, double dummy, active-placebo controlled randomised trial (ABRA)
Conference paper
Ramakrishnan S. et al, (2024), ‘The Famous Five’ – Emerging clinical trial data, A76.2 - A77
Watchful waiting in laryngo‐tracheobronchial amyloid: A case report
Journal article
Beinart D. et al, (2024), Respirology Case Reports, 12
S63 Eosinophilic inflammation at exacerbations of COPD is associated with less dynamic troponin rises in the 30 days post exacerbation
Conference paper
Dobson P. et al, (2024), ‘Firestarter’ – Inflammation, mechanisms and biomarkers in COPD, A49.1 - A49
Steroids in cystic fibrosis exacerbations: are we picking the right patients?
Journal article
Beinart D. et al, (2024), European Respiratory Journal, 64, 2401225 - 2401225
RCT Abstract - Treating eosinophilic exacerbations of asthma and COPD with benralizumab: a double-blind, double-dummy, active-placebo randomised controlled trial (ABRA)
Conference paper
Ramakrishanan S. et al, (2024), Airway pharmacology and treatment, RCT3716 - RCT3716
The healing power of sensory neurons: New horizons for diabetic and neuropathic tissue repair
Journal article
Lu Y. et al, (2024), Clinical and Translational Medicine, 14
Blood eosinophils and lung function loss: from passive prediction to active prevention?
Journal article
Ramakrishnan S. et al, (2024), European Respiratory Journal, 63, 2400812 - 2400812
Multiple Event-time Analysis: A New Approach for Event Based Clinical Trials in Obstructive Airway Diseases
Conference paper
Ramakrishnan S. et al, (2024), A101. FULL METAL JACKET TARGETING COPD AND CHRONIC AIRWAYS DISEASE, A2794 - A2794
Predicting Severe Asthma Attacks With Blood Eosinophils and Exhaled Nitric Oxide (FeNO): Initial Data Analysis for the ORACLE Patient-level Meta-analysis
Conference paper
Couillard S. et al, (2024), C31. WHAT'S NEW IN CLINICAL ASTHMA, A5274 - A5274
Coordinated nasal mucosa-mediated immunity accelerates recovery from COVID-19
Journal article
Cass SP. et al, (2024), ERJ Open Research, 10, 00919 - 2023
The Exacerbation, Not the Patient, Determines Chronic Obstructive Pulmonary Disease Exacerbation Care Seeking
Journal article
Crawford AL. et al, (2024), Annals of the American Thoracic Society, 21, 541 - 542
How have we measured trial outcomes of asthma attack treatment? A systematic review
Journal article
Howell I. et al, (2024), ERJ Open Research, 10, 00660 - 2023
Trailblazing Clinical Trials in Asthma, COPD, Sleep Medicine, and Education and Clinical Practice in 2023
Journal article
Farmer MJS. et al, (2024), CHEST, 165, 19 - 21